In short, our results confirmed that MEF2A transcriptionally activated PSMD14 and that PSMD14 drove the PC disease process by elevating SPON2 expression in an m6A‐RBM15B‐dependent manner. Here, PSMD14 is linked to pachyonychia congenita.